Figure 7
From: Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
FACS analysis of epigenetic modulator treated MCF-7 and MDA-MB-231 cells for 24 h to study the changes cell cycle distribution. (A) AZA, TSA, SFN treatment shows G2/M phase arrest but TSA, SFN treatment were much more effective than AZA. (B) Graphical representation of G1, S, G2/M, and APO population percentage in breast cancer cells (n =3, mean ± S.D.). P <0.05.